J Davignon

Familial hypercholesterolemia in French-Canadians: taking advantage of the presence of a "founder effect".

J. Davignon, J Davignon, M Roy, 1993, The American journal of cardiology.

Apolipoprotein E polymorphism and Alzheimer's disease

S. Gauthier, J. Poirier, S. Gauthier, 1993, The Lancet.

Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects.

M. Tremblay, O. Mamer, P. Barrett, 2000, Journal of lipid research.

Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia.

J. Isaacsohn, R. Goldstein, V. Miller, 1996, JAMA.

Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation.

C. Sing, J. Davignon, J Davignon, 1985, American journal of human genetics.

Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease

J. Poirier, M. Farlow, D. Lahiri, 1998, Neurology.